Polaris is proud to announce that David Davidovic has joined the firm as Senior Advisor. David will be supporting Polaris and its clients on the West Coast out of Polaris’ San Francisco office.
David has been involved in the commercialization of products and in building best-in-class commercial capabilities, including compliance-operations functions, in pharma and biotech for almost 35 years. Most recently, he was Vice President and Global Head of Commercial Services for Roche and Genentech. Prior to joining Genentech, where he spent 8 years, he worked over 23 years for Merck & Co. where he served in multiple marketing, sales, business development, medical education, and commercial operations leadership roles, including marketing, sales, business unit and franchise head positions, in Canada, the US, the Middle East and Africa and globally. David holds a Bachelor of Science and a Masters in Business Administration degrees, both from McGill University in Montreal, Canada.
“We are fortunate to be have been able to attract David to work with Polaris on a part time basis. He brings a wealth of direct industry knowledge and experience and is highly regarded in the field,” said Andy Bender, President and Founder of Polaris. Andy continues “among other responsibilities, David will help grow and support our San Francisco office and client base. This move further underscores our commitment to the strong and evolving biopharma market on the West coast.”